Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial

10-year prevalence of diagnostic and screening colonoscopy use in Germany

(2022) Michel Hornschuch et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial

(2022) Christian Arsov et al.   INTERNATIONAL JOURNAL OF CANCER

Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme

(2022) Max Alterbeck et al.   European Urology Focus

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

(2021) Kimia Kohestani et al.   Scandinavian Journal of Urology

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

(2021) Hendrik Van Poppel et al.   EUROPEAN UROLOGY

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

(2021) Tobias Nordström et al.   LANCET ONCOLOGY

All-Cause Mortality Risk in National Prostate Cancer Cohort: An Impact of Population-Based Prostate Cancer Screening

(2021) Ausvydas Patasius et al.   Journal of Clinical Medicine

Personalized strategies in population screening for prostate cancer

(2020) Sebastiaan Remmers et al.   INTERNATIONAL JOURNAL OF CANCER

PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy Naive Men with Suspected Prostate Cancer: A Narrative Review

(2020) Ivo G. Schoots et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

(2019) Jonas Hugosson et al.   EUROPEAN UROLOGY

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

(2018) Arnout R. Alberts et al.   EUROPEAN UROLOGY

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale

(2017) Anssi Auvinen et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

(2016) Sigrid V. Carlsson et al.   CANCER

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

(2015) Henrik Grönberg et al.   LANCET ONCOLOGY

Inanspruchnahme von Krebsfrüherkennungsuntersuchungen

(2013) A. Starker et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial

(2013) Christian Arsov et al.   EUROPEAN UROLOGY

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostatakarzinomfrüherkennung in Deutschland

(2008) M. Sieverding et al.   UROLOGE